Searchable abstracts of presentations at key conferences in endocrinology

ea0073aep501 | Pituitary and Neuroendocrinology | ECE2021

Clinical features, diagnostic criteria and treatment outcomes in 40 patients with thyrotropin-secreting pituitary tumors

Dimitrova Diana , Przhiyalkovskaya Elena , Grigoriev Andrey , Azizyan Vilen , Lapshina Anastasia , Belaya Zhanna , Melnichenko Galina

IntroductionThyrotropin-secreting pituitary adenomas (TSH-omas) are rare. For this reason each case of TSH-secreting pituitary tumor can help expand extensive clinical experience in world practice.Materials and methodsWe included 40 patients with TSH secreting pituitary adenomas. Hormonal profile: TSH (0.25-3.5 mIU/L), FT4 (9-20 pmol/l) FT3 (2.5-5.5 pmol/l) were measured by Architect i2000SR (Abbott Laborator...

ea0077p3 | Adrenal and Cardiovascular | SFEBES2021

Improving outcomes from SSTS: Redefining Cortisol Cut-Offs

Choudhury Sirazum , Ramadoss Vijay , Lazarus Katharine , Tan Tricia , Meeran Karim

Background: Short Synacthen Tests (SSTs) are integral to the diagnosis of Adrenal Insufficiency (AI). A 30-minute stimulated cortisol value is assessed against local assay dependent thresholds to ascertain or exclude the diagnosis. A diagnosis of AI is a life changing event requiring the initiation of life long glucocorticoid replacement therapy for survival. Glucocorticoid replacement is associated with long term morbidity and mortality, including an increased risk of diabete...

ea0050p183 | Clinical Biochemistry | SFEBES2017

The free androgen index in women is inaccurate when the SHBG concentration is low

Keevil Brian , Adaway Joanne , Fiers Tom , Kaufman Jean-Marc

Introduction: Current clinical practice guidelines recognise that a calculated free testosterone (T) level is the single most-useful, clinically sensitive marker of androgen excess in women, but there is no clear guidance as to the best way to measure free T. Several equations have been proposed to calculate clinically useful estimates of free T including the free androgen index (FAI) and calculated free T (cFT). The FAI is not used in men but it is...

ea0050p187 | Clinical Biochemistry | SFEBES2017

How well can we measure SHBG?

Adaway Jo , Miller Ann Marie , Monaghan Phillip , Merrett Nicola , Keevil Brian , Owen Laura

Sex hormone binding globulin (SHBG) is a glycoprotein which binds hormones such as testosterone. Around 97% of circulating testosterone is bound to SHBG and is therefore biologically unavailable; approximately 2–3% of testosterone is free or loosely bound to proteins such as albumin, and is biologically active, or bioavailable. Free testosterone is very technically challenging to quantify; in order to circumvent this problem, equations are used...

ea0050p183 | Clinical Biochemistry | SFEBES2017

The free androgen index in women is inaccurate when the SHBG concentration is low

Keevil Brian , Adaway Joanne , Fiers Tom , Kaufman Jean-Marc

Introduction: Current clinical practice guidelines recognise that a calculated free testosterone (T) level is the single most-useful, clinically sensitive marker of androgen excess in women, but there is no clear guidance as to the best way to measure free T. Several equations have been proposed to calculate clinically useful estimates of free T including the free androgen index (FAI) and calculated free T (cFT). The FAI is not used in men but it is...

ea0050p187 | Clinical Biochemistry | SFEBES2017

How well can we measure SHBG?

Adaway Jo , Miller Ann Marie , Monaghan Phillip , Merrett Nicola , Keevil Brian , Owen Laura

Sex hormone binding globulin (SHBG) is a glycoprotein which binds hormones such as testosterone. Around 97% of circulating testosterone is bound to SHBG and is therefore biologically unavailable; approximately 2–3% of testosterone is free or loosely bound to proteins such as albumin, and is biologically active, or bioavailable. Free testosterone is very technically challenging to quantify; in order to circumvent this problem, equations are used...

ea0084ps3-15-135 | Thyroid Cancer Diagnosis & Treatment | ETA2022

Clinical relevance of lower titer thyroglobulin (TG) autoantibodies in patients with differentiated thyroid carcinoma

Dekker Bernadette , van der Horst-Schrivers Anouk , Brouwers A.H. , Shuford Chris , Kema Ido , Muller Kobold Anneke , Links Thera

Objectives: Thyroglobulin (Tg) is an established tumor marker for differentiated thyroid carcinoma (DTC) patients. However, Tg immunoassays can be subject to autoantibody (TgAb) interference resulting in incorrect Tg values. Tg measurement with liquid chromatography-tandem mass spectrometry (LC-MS/MS) could be promising in patients with TgAbs. In this study, we compared a Tg immunoradiometric assay (Tg-IRMA) and a Tg-LC-MS/MS analytically in the presence of TgAbs. Furthermore,...

ea0086p167 | Adrenal and Cardiovascular | SFEBES2022

The Value of Baseline Cortisol in Predicting a Preserved Cortisol Response to Synacthen

Suh Sarah , Agha-Jaffar Rochan , Choa Dri , Bravis Vassiliki , Vakilgilani Tannaz , Yee Michael , N Comninos Alexander , Cox Jeremy , Robinson Stephen

Background: Adrenal Insufficiency (AI) presents a diagnostic and clinical challenge. While short Synacthen Tests (SSTs) are most commonly utilised to diagnose AI, the value of a baseline cortisol is being explored. We aimed to review indications for performing an SST and to determine the baseline cortisol that predicted a preserved cortisol response to Synacthen.Methods: Eight hundred and sixty SSTs performed in 621 individuals at a tertiary endocrinolog...

ea0086p368 | Thyroid | SFEBES2022

Falsely elevated serum TSH in a mother and her four children

Darrat Milad , Shah Shilpa , Halsall David , Schoenmakers Nadia , Bradley Una

Background: Elevated TSH concentration should be assessed and treated with caution because of the possibility of transient thyroid dysfunction, or, in rare cases, measurement interference. We describe a case with a rare cause of elevated TSH level in a 39-year-old mother and her four children.Case Summary: A 39-year-old lady was referred with a long history of high serum TSH ranging between 18.9 to 38.7 (reference interval 0.4-4.0 mU/l) with FT4 concentr...

ea0065p11 | Adrenal and Cardiovascular | SFEBES2019

Cosyntropin stimulation test post unilateral adrenalectomy for non-steroid secreting lesions: not all who fail require steroids

Zaman Shamaila , Almazrouei Raya , DiMarco Aimee , Palazzo Fausto , Wernig Florian

Aim: Recent studies reported a wide range in baseline and peak cortisol responses to surgery. We report the results of cosyntropin stimulation testing following unilateral adrenalectomy for non-steroid secreting lesions.Methods: Data of 36 patients who underwent cosyntropin stimulation testing on the second day post unilateral adrenalectomy were collected retrospectively. None of the patients had clinical signs of hypercortisolism. No patient received pr...